Lactococcus garvieae is an emerging pathogen in aquaculture, increasingly associated with disease outbreaks in tilapia farming across Asia. We investigated two outbreaks affecting cage-cultured tilapia (Oreochromis spp.) in Northern Vietnam in 2024.
Affected fish presented with exophthalmia, scale hemorrhages, hepatobiliary enlargement, ascites, intestinal hemorrhage, and empty gastrointestinal tracts (Fig. 1). Initial biochemical profiling misidentified the isolates as Streptococcus agalactiae ; however, species identity was confirmed as L. garvieae by MALDI-TOF mass spectrometry and 16S rRNA gene sequencing. Whole-genome sequencing of eight isolates demonstrated marked genomic homogeneity. All strains belonged to multilocus sequence type ST95 and differed by ≤9 core genome SNPs. Phylogenomic analysis placed the Vietnamese isolates within a clonal subclade together with ST95 strains from fish and humans in East Asia, suggesting recent regional expansion and possible transmission across sectors.
Screening for antimicrobial resistance genes identified only mdt(A) and lsaD, consistent with phenotypic resistance to erythromycin, tetracycline, and doxycycline. No plasmid-associated resistance determinants were detected. All isolates harbored the full complement of 53 known virulence-associated genes, including capsule biosynthesis loci, hemolysins (hly1–3), and LPxTG-anchored adhesins, supporting their high pathogenic potential and explaining the severe clinical presentation.
These findings document the emergence of a highly clonal L. garvieae ST95 lineage in Vietnamese aquaculture, characterized by elevated phenotypic antimicrobial resistance and conserved virulence gene content. The results underscore the need for routine genomic surveillance and strengthened biosecurity to limit further dissemination. Given the limited therapeutic options and increasing global incidence of L. garvieae infections in aquaculture, vaccine development should be prioritized.